Roche chairman sees greater flexibility after Novartis deal

Roche's $20.7 billion move to buy back nearly a third of its voting stock from fellow Swiss drugmaker Novartis will give it more strategic flexibility, Chairman Christoph Franz said in an... | November 6, 2021

Related Keywords

Switzerland , Swiss , Gareth Jones , John Revill , Novartis , Annual General Meeting , Novartis Ag Stock Exchange , News , Information , Press Release , Billion , Cove , O , Guy , Back , Early , Third , F , Its , Voting , Stock , Rom , Fellow , Drugmaker , Hill , Five , It , More , Strategic , Chairman , Christoph , Franz , Aid , N Novn Ch0012005267 ,